Conexa Saúde
PrivateLast Round
Early Funding
Dec 13, 2023
Total Funding Raised
$51.83M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Conexa Saúde operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was an Early Funding round in December 2023.
Conexa Saúde is a healthtech company that provides a comprehensive digital healthcare ecosystem offering telemedicine, mental health services, and primary care solutions for individuals and corporate clients.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Mental Health, InsurTech
Business Model
B2B2C
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Conexa Saúde Comparables
Compare Conexa Saúde with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Starbem | 77% | |
| Llamando al Doctor | 76% | |
| StoneCo Ltd. | 73% |
For institutional investors. Book with your work email.
Conexa Saúde Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Dec 13, 2023 | ||||
| Series C | Jun 27, 2022 | ||||
| Series B | Jun 25, 2020 | ||||
| Seed | Feb 18, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Conexa Saúde Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Igah Ventures | Series B |
| Kamaroopin | Early Funding |
| e.Bricks Ventures | Series B, Seed |
| Goldman Sachs Asset Management Private Equity | Series C |
| Vivo Ventures | Early Funding |
| Igah Ventures | Series C, Early Funding |
| Goldman Sachs | Early Funding, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 10, 2026
Facilitates over 7.2 million consultations annually.
- May 10, 2026
Now covers over 35 million eligible lives.
For institutional investors. Book with your work email.
Conexa Saúde Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Conexa Saúde's valuation, stock price, and market status.
Is Conexa Saúde a public or private company?
Conexa Saúde is a private company.
What is the current stock price of Conexa Saúde?
Conexa Saúde is a private company, so its shares have no public market price. Caplight tracks Conexa Saúde's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Conexa Saúde worth (valuation)?
Valuation information for Conexa Saúde is not publicly available.
Can I buy Conexa Saúde stock?
Conexa Saúde shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Conexa Saúde's last funding round?
Conexa Saúde's most recent funding round was Early Funding on December 13, 2023.
Who are the main investors in Conexa Saúde?
Key investors in Conexa Saúde include Igah Ventures, e.Bricks Ventures, Goldman Sachs Asset Management Private Equity, Vivo Ventures, Goldman Sachs.
Will Conexa Saúde IPO soon?
No public IPO plans have been announced for Conexa Saúde.
How can I track Conexa Saúde secondary market activity?
Caplight tracks bids, offers, and trades in Conexa Saúde's shares on secondary markets.